UnitedHealth Group Incorporated (UNH) — closed signal from July 13, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on October 11, 2025.
Predicted vs. what happened
What happened
Reached its target in 58 days.
The thesis — published July 13, 2025
The share price is showing signs of recovery right when legal news is loudest. More buyers than usual are stepping in, even with the DOJ looking at the company. Picking up shares around $300 305 could lead to about 15 percent gains if July results ease the legal worry and prove cash is still strong. Because lawsuits are unresolved, we are only watching for now.
Primary drivers
- Recent price turn hints at a new rise despite the ongoing legal probe.
- Big investors are buying before the earnings release.
- Health insurance often stays solid when the wider economy is shaky.
- July earnings might shift focus back to steady profit growth.
How it played out
UNH: target reached in 58 days
On July 13, 2025, Lyra published a short-term UNH watch at $300.18, with expected growth of 15% and a target of $340.75. The thesis pointed to a recent price turn, bigger investor buying before earnings, health insurance holding up when the economy was shaky, and July earnings shifting focus back to steady profit growth.
Inside the window, UNH reached the target in 58 days. It peaked at $373.71 on October 9, 2025, with a 24.5% gain. The window ended at $352.13, still above the target. The thesis played out.
What happened during the window
On July 29, 2025, UnitedHealth reported second-quarter results and restored its 2025 outlook. On July 29, 2025, Axios reported that the company planned remediation actions after medical costs rose in the quarter.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.